Funmilola Fisusi is a Lecturer in Pharmaceutics in the School of Applied Sciences at the University of Brighton. She has a Bachelor of Pharmacy (BPharm) degree and MSc in Pharmaceutics from Obafemi Awolowo University, Ile-Ife, Nigeria. She obtained a PhD in Drug Delivery from the UCL School of Pharmacy, University College London. Her PhD research focused on the application of nanoparticle-based strategy for safer and more effective therapy of glioblastoma. She previously worked as a Research Fellow and Lecturer at Obafemi Awolowo University, Ile-Ife, Nigeria. She also carried out post-doctoral research on the development of monoclonal antibody conjugates for the synthesis of multifunctional nanoparticles for targeted therapy of breast cancer and HIV at Howard University, Washington DC, USA.

My research interest is in safe and effective nanoparticle-based drug delivery for cancer therapy, especially breast and brain cancers.  This comes from my keen interest in exploring the seemingly limitless potentials of the nanotechnology platform to transform therapeutic outcomes in the setting of diseases such as cancer which continue to have mostly dismal prognosis despite decades of intensive research efforts. I am interested in targeted delivery of therapeutic molecules to brain and peripheral tumours such as breast cancers for better efficacy and minimal side effects, which would result in improved therapeutic outcomes.

I am also interested in the design and development of novel anticancer and antimicrobial peptides. The goal of this research is to generate a library of peptide-based therapeutic molecules with potentials for dual anticancer and antimicrobial properties for targeted therapy using the nanotechnology platform.

Current research activities

Drug repurposing for cancer therapy - repurposing of selected clinically used antiinfective agents for nanoparticle-based combination therapy for breast and brain cancers.

Currently accepting motivated PhD students with own funding.

I am interested in the developemnt of nanoparticle-based therapies for the therapy of breast and brain cancers. 

Current projects available for MRES/PhD supervision:

1. Nano-enabled drug development for glioblastoma therapy using drug repurposing strategy

2. Nano-enabled drug drug development for breast cancer therapy using drug repurposing strategy

3. Development of peptide-based therapeutics for cancer therapy

4. Development of peptide-based drug delivery systems